Prophylactic Application of Nebulized Liposomal Amphotericin B in Hematologic Patients with Neutropenia

Publisher： Karger

E-ISSN： 2296-5262|34|5|254-258

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.34, Iss.5, 2011-04, pp. : 254-258

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Economic evaluation of caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia in Sweden

By Naik Shalini   Lundberg Johan   Kumar Ritesh   Sjolin Jan   Jansen Jeroen P.  

Scandinavian Journal of Infectious Diseases, Vol. 43, Iss. 6-7, 2011-07 ,pp. : 504-514

Informa Healthcare

Access to resources Recommend Favorite

Cost-Benefit Assessment of Antifungal Prophylaxis with Liposomal Amphotericin B in Neutropenic Patients

By  

Oncology Research and Treatment, Vol. 30, Iss. 12, 2007-11 ,pp. : 621-626

Karger

Access to resources Recommend Favorite

Haemopoietic Cell Transplantation of Patients with a History of Deep or Invasive Fungal Infection during Prophylaxis with Liposomal Amphotericin B

By  

Acta Haematologica, Vol. 113, Iss. 2, 2005-03 ,pp. : 104-108

Karger

Access to resources Recommend Favorite

Effect of Discontinuing Prophylaxis with Norfloxacin in Patients with Hematologic Malignancies and Severe Neutropenia

By  

Acta Haematologica, Vol. 99, Iss. 4, 1998-05 ,pp. : 206-211

Karger

Access to resources Recommend Favorite

Evaluation of the safety and efficacy of liposomal amphotericin B (L-AMB) in children

By Sunakawa Keisuke  

Journal of Infection and Chemotherapy, Vol. 18, Iss. 4, 2012-08 ,pp. : 456-465

Springer Publishing Company

Access to resources Recommend Favorite